New pessary system aims to ease pelvic organ prolapse management at home
NCT ID NCT06634459
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a new pessary system designed for easier home use in women with pelvic organ prolapse. About 200 women who have never used a pessary will be randomly assigned to either the new system or standard care. The main goal is to see if the new system leads to higher satisfaction over six months.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Reia System (pessary and applicator) or standard pessary (Gellhorn or ring)
What this could lead to
If successful, this could offer women with pelvic organ prolapse a more convenient and satisfying way to manage their condition at home.
What could go wrong
This is a relatively small, early-stage trial focused on satisfaction and ease of use, not a cure. The new device may not prove better than standard options and could have unforeseen complications.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PELVIC ORGAN PROLAPSE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Atrium Health Wake Forest Baptist
RECRUITINGWinston-Salem, North Carolina, 27103, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Dartmouth-Hitchcock
RECRUITINGLebanon, New Hampshire, 03756, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
MedStar Health
RECRUITINGWashington D.C., District of Columbia, 20010, United States
Contact
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
-
Stanford University
RECRUITINGPalo Alto, California, 94304, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The University of Chicago
RECRUITINGNorthbrook, Illinois, 60062, United States
Contact
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact
Contact
Contact
-
University of Alabama at Birmingham
RECRUITINGBirmingham, Alabama, 35249, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact
Contact
-
University of New Mexico Health Sciences Center
RECRUITINGAlbuquerque, New Mexico, 87131, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Wisconsin
RECRUITINGMadison, Wisconsin, 53711, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Women & Infants Hospital in Rhode Island
RECRUITINGProvidence, Rhode Island, 02903, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••